Robotic Ileal Interposition Surgery with Duodenal Exclusion and Sleeve Gastrectomy For Diabetes: The First Case Report and 1-Year Follow-Up

1. Introduction
Responsible for more than one hundred billion in direct public spending on their treatment and controls, diabetes mellitus and obesity are public health problems, both correlated with each other [1]. Despite the therapeutic advances, these two conditions do not have a definitive cure by conservative treatment and require strict continuous clinical control [2]. In this context, ileal interposition with duodenal exclusion and sleeve gastrectomy, also known as metabolic surgery, is increasingly used as an effective measure for treating type 2 diabetes (DM2) [3]. Despite robotic surgery is a great advance, this surgical procedure is usually performed by laparoscopy [4]. Up to the time of this surgery (July 20, 2021),
the authors have not identified in the scientific literature (Pubmed/ Medline Database, BVS) any description of this technique using
robotics, presenting here what appears to be the first case report and with a one-year follow-up.